Welcome to our dedicated page for Constellium Se SEC filings (Ticker: CSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Constellium SE (NYSE: CSTM) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As an NYSE‑listed issuer of ordinary shares, Constellium submits periodic and current reports that describe its financial condition, segment performance, governance changes and other material events.
Among the most relevant documents for investors are current reports on Form 8‑K. Constellium uses Form 8‑K to announce results of operations and financial condition under Item 2.02, typically in connection with quarterly earnings releases and investor presentations. These filings reference detailed press releases and slide decks that include shipments, revenue, net income, Adjusted EBITDA, Segment Adjusted EBITDA for the Aerospace & Transportation (A&T), Packaging & Automotive Rolled Products (P&ARP) and Automotive Structures & Industry (AS&I) segments, as well as the impact of metal price lag.
Constellium also files 8‑Ks under Item 5.02 to disclose departures and appointments of directors and certain officers and related compensatory arrangements. For example, the company has reported the Board’s decision to appoint Ingrid Joerg as Chief Executive Officer and director, effective January 1, 2026, and has outlined the key terms of her employment agreement. The same filing describes the planned transition of Jean‑Marc Germain to a Special Advisor role and summarizes his transition agreement.
Over time, investors can also review annual reports on Form 10‑K and quarterly reports on Form 10‑Q (when available) to analyze Constellium’s consolidated financial statements, risk factors, segment information, discussion of metal price lag and explanations of trends in its aerospace, packaging, automotive and industrial businesses. Forms 3, 4 and 5, when filed, provide data on insider holdings and changes in ownership by directors and officers.
Stock Titan enhances these filings with AI-powered summaries that explain key points in plain language, highlight important changes from prior periods and draw attention to items such as segment performance, leverage metrics, share repurchases, leadership changes and compensation arrangements. Real-time updates from EDGAR help ensure that new CSTM filings, including 10‑K, 10‑Q, 8‑K and insider transaction reports, appear promptly so users can review the underlying documents and AI insights in one place.
Jurkovic Philip Ryan reported acquisition or exercise transactions in this Form 4 filing.
Constellium SE senior vice president and CHRO Philip Ryan Jurkovic received a grant of 10,210 restricted stock units representing ordinary shares as executive compensation. The award was reported at a price of zero per share and increases his direct holdings to 220,933 ordinary shares.
The restricted stock units vest in full on March 12, 2029, subject to his continued employment, meaning he must remain with the company until that date to receive the underlying shares.
CONSTELLIUM SE senior vice president Ludovic Piquier reported an acquisition of 5,469 ordinary shares through a grant of restricted stock units. The units were granted at no cash cost and will vest in full on March 12, 2029, conditioned on his continued employment.
Following this equity award, Piquier directly holds 242,713 ordinary shares. This filing reflects a compensation-related stock grant rather than an open-market purchase or sale, increasing his long-term ownership stake in the company.
Becker Marcus reported acquisition or exercise transactions in this Form 4 filing.
Constellium SE reported that senior vice president and chief procurement officer Marcus Becker received a grant of 3,938 restricted stock units representing ordinary shares. These units were awarded at no cash cost and vest in full on March 12, 2029, subject to his continued employment. Following this compensation-related award, Becker directly owns 37,175 ordinary shares.
Joerg Ingrid reported acquisition or exercise transactions in this Form 4 filing.
CONSTELLIUM SE CEO Ingrid Joerg received a compensation-related equity grant. On March 12, 2026, she was awarded 31,358 ordinary shares in the form of restricted stock units, which vest in full on March 12, 2029, subject to continued employment. After this grant, she directly holds 409,448 shares.
Perkins Matthew B. reported acquisition or exercise transactions in this Form 4 filing.
CONSTELLIUM SE reported that executive Matthew B. Perkins, President, P&ARP, received an equity award in the form of 10,210 ordinary shares on March 12, 2026. The award was recorded at a price of $0.00 per share, indicating it is a compensation grant rather than an open-market purchase.
According to the footnote, this represents a grant of restricted stock units that vest in full on March 12, 2029, provided he remains employed through that date. Following this grant, Perkins directly holds 33,212 ordinary shares, reflecting his ongoing equity-based alignment with the company.
Schild Niklaus reported acquisition or exercise transactions in this Form 4 filing.
Constellium SE senior vice president and chief information and digital officer Niklaus Schild reported an equity compensation award. He received 3,355 restricted stock units tied to Constellium ordinary shares, granted at no purchase price. These units vest in full on March 12, 2029, subject to his continued employment.
Following this grant, Schild directly holds 38,703 ordinary shares of Constellium. The transaction reflects routine stock-based compensation rather than an open-market share purchase or sale.
Hoffmann Philippe reported acquisition or exercise transactions in this Form 4 filing.
CONSTELLIUM SE reported that President, A&T Philippe Hoffmann received an equity award in the form of restricted stock units. On March 12, 2026, he was granted 12,033 ordinary shares at a price of $0.00 per share as compensation. Following this grant, his direct holdings increased to 194,153 ordinary shares. According to the disclosure, these restricted stock units vest in full on March 12, 2029, provided he remains employed with the company through that date.
Corre Stephane reported acquisition or exercise transactions in this Form 4 filing.
Constellium SE reported that executive Stephane Corre, President of Automotive Structures & Industry, received a grant of 7,293 ordinary shares in the form of restricted stock units at no cash cost. These units vest in full on March 12, 2029, contingent on his continued employment. Following this equity award, Corre directly holds 72,313 ordinary shares of Constellium, aligning a portion of his compensation with the company’s long-term share performance.
Guo Jack Q. reported acquisition or exercise transactions in this Form 4 filing.
Constellium SE EVP & CFO Jack Q. Guo received a grant of 19,690 ordinary shares in the form of restricted stock units, with no purchase price.
Following this award, he directly holds 210,569 ordinary shares. The RSUs vest in full on March 12, 2029, subject to continued employment.
Constellium SE announced that its Board of Directors has authorized a new share repurchase program of up to $300 million of outstanding ordinary shares. The program will become effective after the 2026 Annual General Meeting on May 21, 2026 and run through December 31, 2028, replacing the program approved in February 2024.
The company may buy back shares for cash in open-market or privately negotiated transactions and can use Rule 10b5-1 plans, in line with U.S. securities rules and French corporate law. The Board is not required to repurchase any specific amount and may modify, suspend, extend, or terminate the program at any time. Management highlights this authorization as part of a balanced capital allocation strategy to return capital to shareholders. Constellium reports $8.4 billion of revenue in 2025.